SCHEMBL8042935

SCHEMBL8042935

CCc1ccccc1-n1nnc(Sc2nccs2)n1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.36
FBP1 P09467 4/20 0.35
TDP1 Q9NUW8 1/20 0.35
GRM5 P41594 2/20 0.34
SCN9A Q15858 1/20 0.32
PDK1 Q15118 1/20 0.32
PKM P14618 1/20 0.32
RECQL P46063 1/20 0.32
HTR7 P34969 1/20 0.31
DCUN1D1 Q96GG9 2/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
MGLL Q99685 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8042054 0.81 ALDH1A1 (0.43) NPC1RAB9APKM
SCHEMBL8048790 0.79 RAB9A (0.44) NPC1RAB9ASMN1; SMN2TDP1HTR7
SCHEMBL8048729 0.77 ELANE (0.47) NPC1RAB9ASMN1; SMN2FBP1TDP1
SCHEMBL8050908 0.76 ELANE (0.31)
SCHEMBL8046787 0.76 ALDH1A1 (0.42) SMN1; SMN2TDP1PKM
SCHEMBL8042803 0.75 MAPK8 (0.46) NPC1RAB9ASMN1; SMN2TDP1
SCHEMBL8044613 0.75 ALDH1A1 (0.38) SMN1; SMN2
SCHEMBL8050943 0.73 FBP1 (0.42) SMN1; SMN2FBP1PDK1HTR7DCUN1D1
SCHEMBL8032825 0.72 HSP90AA1 (0.40) NPC1RAB9ASMN1; SMN2TDP1PKM
SCHEMBL8043989 0.71 FBP1 (0.42) NPC1RAB9AFBP1PDK1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080772-A 2-AMINOTHIAZOLE TRIAZOLE OR TETRAZOLE COMPOUND FOR REGULATING PROTEIN TYROSINE PHOSPHATASE ACTIVITY SUGEN, INC. (US) 2000-06-27 US disclosed
WO-1998027092-A1 THIAZOLE COMPOUNDS AND METHODS OF MODULATING SIGNAL TRANSDUCTION SUGEN, INC. (US) 1998-06-25 WO disclosed